CYTOSORBENTS CORPORATION Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months
CYTOSORBENTS CORPORATION (CTSO) had Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months of $1.90 million as of 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Notes › Leases › Lessee, Operating Lease, Liability, to be Paid, Rolling Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths · last filed 2022-03-10
- 2021-12-31: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $1.90M.
- 2021-09-30: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $1.60M.
- 2021-06-30: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $1.54M.
- 2021-03-31: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $462.90K.
| Period end | Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months |
|---|---|
| 2021-12-31 | $1.90M 10-K · filed 2022-03-10 |
| 2021-09-30 | $1.60M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.54M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $462.90K 10-Q · filed 2021-05-04 |
| 2020-12-31 | $447.49K 10-K · filed 2021-03-09 |
| 2020-09-30 | $432.42K 10-Q · filed 2020-11-04 |
| 2020-06-30 | $417.70K 10-Q · filed 2020-08-04 |
| 2020-03-31 | $442.87K 10-Q · filed 2020-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |